Eli Lilly's $1 Billion Lifeline: Transforming Telangana's Pharma Landscape
US pharmaceutical giant Eli Lilly is set to invest $1 billion in Telangana, enhancing its manufacturing and global medicine supply capacity. The decision was announced after meetings with Telangana officials. The expansion will include a new plant, creating significant employment opportunities for local youth.
- Country:
- India
US pharmaceutical giant Eli Lilly announced a substantial investment of $1 billion in Telangana to bolster its manufacturing and global medicine supply operations, the state government revealed on Monday.
The announcement followed discussions between Eli Lilly's global delegation and Telangana's Chief Minister A Revanth Reddy along with Industries Minister D Sridhar Babu at the Integrated Command Control Centre. An official release hailed this development as a major win for Telangana, emphasizing the boost to its pharma landscape.
The investment will pave the way for a new manufacturing plant and quality center, which promises to generate significant employment opportunities for the skilled youth of Telangana.
(With inputs from agencies.)
Advertisement
ALSO READ
Poultry Power: The 17th Annual Poultry India Expo Takes Center Stage in Hyderabad
Eli Lilly to Invest $1 Billion in India, Establish New Hyderabad Hub
Hyderabad's Bus Fare Hike Sparks Outrage: KTR Slams Congress Government
Green Exports: Driving Sustainable Growth in Indian Manufacturing
India's Electronics Manufacturing Gets a Boost with Record Investment Proposals
Google News